From Ischemia to Imaging: Evolving Diagnostic Frontiers in Cardiovascular Medicine
Author(s):
Cardiovascular diagnostics have undergone a paradigm shift from functional ischemia assessment to precision imaging and molecular profiling. This review examines five transformative technologies: (1) coronary computed tomography angiography (CCTA)-derived fractional flow reserve (FFR-CT), (2) cardiac magnetic resonance (CMR) tissue characterization, (3) artificial intelligence (AI)-enhanced echocardiography, (4) molecular imaging of inflammation, and (5) wearable continuous monitoring. Analysis of 50 clinical studies demonstrates FFR-CT's 85% diagnostic accuracy (vs. invasive FFR), while CMR late gadolinium enhancement predicts major adverse cardiac events (MACE) with 92% sensitivity. AI algorithms now quantify ejection fraction within 2% of expert measurements, and 18F-FDG PET detects high-risk plaques with 89% specificity. Despite these advances, challenges persist in cost-effectiveness (only 35% of centers utilize CMR routinely) and data integration. We propose a tripartite implementation strategy combining (i) standardized imaging protocols, (ii) AI-powered decision support, and (iii) multidisciplinary team-based interpretation. The future promises liquid biopsy-based ischemia detection and quantum computing-enhanced imaging reconstruction, positioning cardiovascular medicine at the forefront of precision diagnostics.